CBD & Human Health
Looking to launch a hemp CBD, hemp food or hemp pharma product line, or to invest in this exciting sector? Join us August 19-20, 2022 for an exclusive, intensive Summit with industry leading experts.
This is a special invitation for you to join us for The Future of Medical Hemp, a part of the Hemp | 2020 Business Summit Series hosted by HempToday, the leading media & networking center for the global hemp industries.
What we’ll explore:
The Summit, to be held at HempToday Center in The Palace at Nakło, Lelów, Poland, will look at the current status of the CBD sector and the many opportunities that exist in the exciting field of medical hemp & health products. We will explore the basics of cannabinoid extraction, and point to the sub-sectors, products and supporting industries that are coming into play. We’ll look at the sector’s wide range of specialized services – research & product development; marketing & communications, and technology & machinery.
- Regulatory environment
- Biochemistry of cannabinoids
- CBD production process
- Product development & innovation
- Global hot spots for medical hemp
We invite current stakeholders, investors, entrepreneurs, economic development specialists, researchers, graduate students, doctors, scientists, developers, processors and marketers to apply for The Future of Medical Hemp. We make a conscious effort to assemble a group of participants who have common business interests, with a goal to foster creative relationships through which everyone can advance individual business goals and the hemp industries overall.
A dynamic CBD market
The most lucrative derivative of the hemp plant, CBD, has proven effective in a variety of illnesses and maladies. Its acceptance around the world is growing as studies prove its benefits to those suffering chronic pain and seizures along with a wide range of other afflictions. Major research and development projects are under way worldwide while sales of CBD continue double-digit growth year-on-year.
Development top to bottom
The CBD sector is developing at all levels, among small entrepreneurs; and among legacy players all the way up to public markets around the world. HempToday envisions a wave of mergers throughout 2018 while small, creative companies continue to bubble up from the startup scene. CBD and other hemp-based health products also have the potential to transform agriculture in many parts of the world — both at the local level and across vast commercial farms in North America, China, India and South America.
Aims of the Summit
- To share knowledge and experiences
- To foster business matchmaking among participants
- To generate a body of content for broader distribution around the world
- To jointly explore hemp’s potential as an engine for sustainable economic development
Speaker Application 2022
If you would like to speak at The Future of Medical Hemp 2022, please use this form to submit your application. Speaker selections are made after June 30, 2022. All applicants will be notified regarding speaker selection. If you are accepted as a presenter, you pay the discounted accreditation fee of €999 + VAT. Speaker selections are at the discretion of organizers.
Speakers last edition (2019)
Managing Director, European Industrial Hemp Association
A veteran policy advisor and communication manager at the European level, Lorenza has led EIHA’s efforts in Brussels since February 2019. She has worked with a number MEPs to propose hemp reforms to the Common Agriculture Policy in the European Union. Lorenza previously advised interests in the oil and gas sector, and led the European Association of Independent Winegrowers. She is a native of Italy and graduated from the University of Gorizia with a Master of Arts in European Affairs.
International Cannabis & Cannabinoids Institute
Steph is Director of Innovations at the International Cannabis and Cannabinoids Institute (ICCI) and founder and executive director of Americans for Safe Access (ASA), the USA’s leading medical cannabis patient advocacy organization. Prague-based ICCI is dedicated to the standardization of industrial hemp production for CBD and other compounds which address human health. ASA’s advises the American Herbal Products Association (AHPA) on standards for the emerging medical cannabis industry. Steph is also a founding member of International Medical Cannabis Patients Coalition (IMCPC).
Jacek Kramarz, Poland
Chief of Sales, HemPoland/CannabiGold
Under Jacek’s leadership, HemPoland’s blue-chip CannabiGold brand has quickly worked its way into the leading ranks of global CBD purveyors. Jacek previously worked in management consulting in Vienna where he coordinated international projects tackling complex changes in company ownership and restructuring. He is also a licensed securities broker.
Boaz Wachtel, Israel
Chairman & Co-Founder, CresoPharma
A long-time cannabis activist and entrepreneur, Boaz was co-founder and former managing director of MMJ Phytotech, Australia’s first publicly traded medical cannabis company. His current company, Creso Pharma, a nutraceuticals maker, is traded on the Australian Securities Exchange (ASX). Boaz is also co-founder and inventor at rootssat.com, the developer of root zone heating and cooling technology, and co-founder of the International Medical Cannabis Patient Coalition (IMCPC).
Scott Reese, USA
CEO, C-Beyond-Health, Colorado
Scott is an entrepreneur, inventor and pharmaceutical marketing executive who has launched and managed brands for Astrazeneca, BMS, Pfizer, Genentech and many other pharmaceutical companies. Scott has presented to the U.S. Congress and the U.S. Food and Drug Administration’s committee on social media and health informatics. He has appeared in numerous industry publications including Pharmaceutical Executive, MM&M and PM360. Scott served on the Global Envisioning Board for an international marketing communications conglomerate and on the Marketing Innovations Board for a global pharmaceutical company.
Boris Banas, Slovakia
CBDepot, Czech Republic
A hemp activist since 1998, Boris, who serves as CSO at CBDepot, started growing hemp for research under Slovak government licenses in 1999, and ultimately helped to push the Slovak government to adopt EU hemp-related farming rules in 2008. He launched CBDepot in 2014 with a mission to provide legal, high quality cannabidiol-enriched products for the industrial and consumer markets. He is also co-founder and co-owner of Hemp Seed Oil Europe, ltd, a supplier of bulk and private label hemp seed derivatives. Boris is a graduate of the School of Finance, Matej Bel University, Slovakia.
Muhammed A Qayyum, Pakistan
Co founder & CEO Fytocina SL
Muhammed is a natural products specialist and innovator working in herbals and nutraceuticals. Before starting Fytocina SL, Muhammed was managing his family business of manufacturing herbal medicines in Pakistan. He has served as an officer in a number of professional groups in the pharmaceutical, nutraceutical and traditional medicine sectors. Muhammed served a a consultant to the World Health Organization in 2003 and 2005, advising on Good Manufacturing Practices, policy and regulatory framework for traditional medicines.
MH medical hemp GmbH, Germany
Joscha is CEO at MH medical hemp GmbH, Germany, which makes CBD and a line of CBD-infused cosmetics. He is active worldwide in the areas of medicinal cannabis and CBD. Joscha holds an M.S. in ecology, and is a master class graduate at Dutch medicinal hemp producer Bedrocan, where he studied cannabis cultivation and cannabinoid extraction.
CEO, Hempoint, Czech Republic
Hana is one of Europe’s pioneering and most innovative hemp entrepreneurs and activists. She is a widely recognized expert and consultant on everything from hemp farming to patient focused certification (PFC) for medical cannabis, through her affiliation with the Prague-based International Cannabis and Cannabinoids Institute. Hana’s company advises farmers on hemp cultivation, and is an organic hemp food producer.